{"nct_id":"NCT00606476","title":"AAB-001 (Bapineuzumab) Open-Label, Long-Term Extension Study in Patients With Mild to Moderate Alzheimer's Disease","status":"TERMINATED","status_verified_date":"2012-08","start_date":"2006-12","start_date_type":null,"primary_completion_date":"2012-09","primary_completion_date_type":"ACTUAL","completion_date":"2012-09","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["JNJ"]}